JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NVO
4526
CALL
Novo Nordisk
NVO
$166B
| $338K | ﹤0.01% |
+5,000
| New | +$293K |
2022 Q4
0 quarters
|
|
|
OLO
4527
DELISTED
Olo Inc
OLO
| $338K | ﹤0.01% |
54,061
-119,964
| -69% | -$905K |
2021 Q1
7 quarters
|
|
4528
Adams Diversified Equity Fund
ADX
$3.28B
| $337K | ﹤0.01% |
23,153
+17,003
| +276% | +$258K |
2015 Q4
28 quarters
|
|
4529
PubMatic
PUBM
$836M
| $336K | ﹤0.01% |
26,202
+2,700
| +11% | +$42.3K |
2020 Q4
8 quarters
|
|
4530
ProShares Short S&P500
SH
$968M
| $336K | ﹤0.01% |
5,234
-2,502
| -32% | -$160K |
2018 Q3
17 quarters
|
|
4531
Ceragon Networks
CRNT
$194M
| $335K | ﹤0.01% |
175,349
+4,322
| +3% | +$8.11K |
2021 Q1
7 quarters
|
|
4532
Century Therapeutics
IPSC
$239M
| $335K | ﹤0.01% |
65,461
+2,360
| +4% | +$22.3K |
2021 Q3
5 quarters
|
|
4533
Stoneridge
SRI
$185M
| $335K | ﹤0.01% |
15,529
+914
| +6% | +$19.6K |
2013 Q2
38 quarters
|
|
|
EXEEL
4534
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
| – | – |
0
| – | – |
2021 Q1
7 quarters
|
|
4535
Anika Therapeutics
ANIK
$256M
| $334K | ﹤0.01% |
11,264
+658
| +6% | +$18.7K |
2015 Q4
28 quarters
|
|
4536
Canadian Solar
CSIQ
$784M
| $333K | ﹤0.01% |
10,761
-255,188
| -96% | -$8.57M |
2013 Q3
37 quarters
|
|
4537
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.41B
| $332K | ﹤0.01% |
+24,671
| New | +$337K |
2022 Q4
0 quarters
|
|
4538
CALL
Sherwin-Williams
SHW
$78B
| $332K | ﹤0.01% |
+1,400
| New | +$324K |
2022 Q4
0 quarters
|
|
4539
BayCom
BCML
$338M
| $331K | ﹤0.01% |
17,406
-8,260
| -32% | -$155K |
2018 Q2
18 quarters
|
|
4540
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.43B
| $331K | ﹤0.01% |
6,978
-12,472
| -64% | -$590K |
2016 Q4
24 quarters
|
|
4541
RUM Group Inc
RUM
$3.79B
| $331K | ﹤0.01% |
55,597
-186,231
| -77% | -$1.79M |
2022 Q3
1 quarter
|
|
|
BLFY
4542
DELISTED
Blue Foundry Bancorp
BLFY
| $330K | ﹤0.01% |
25,676
+11,307
| +79% | +$140K |
2021 Q3
5 quarters
|
|
4543
Gran Tierra Energy
GTE
$370M
| $330K | ﹤0.01% |
33,407
-10,428
| -24% | -$123K |
2017 Q2
22 quarters
|
|
|
JAQC
4544
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $330K | ﹤0.01% |
33,350
-135,800
| -80% | -$1.33M |
2021 Q4
4 quarters
|
|
4545
Breakwave Dry Bulk Shipping ETF
BDRY
$34.9M
| $328K | ﹤0.01% |
+35,674
| New | +$304K |
2022 Q4
0 quarters
|
|
4546
Millicom
TIGO
$15.2B
| $328K | ﹤0.01% |
25,984
+14,909
| +135% | +$187K |
2020 Q1
11 quarters
|
|
|
RAPT
4547
DELISTED
RAPT Therapeutics
RAPT
| $326K | ﹤0.01% |
2,061
+9
| +0.4% | +$1.44K |
2019 Q4
12 quarters
|
|
|
CVT
4548
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $326K | ﹤0.01% |
60,393
+4,579
| +8% | +$25.4K |
2022 Q1
3 quarters
|
|
4549
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.01B
| $325K | ﹤0.01% |
5,576
| – | – |
2016 Q4
24 quarters
|
|
4550
Shore Bancshares
SHBI
$756M
| $325K | ﹤0.01% |
18,690
+1,467
| +9% | +$27.5K |
2021 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.